WellCell Holdings Co., Limited will hold its annual general meeting on 27 May 2026 in Zhuhai. Key proposals include:

• Capital mandates – Issue Mandate: authorises the Board to allot and issue up to 800.00 million new shares, equivalent to 20% of the current 4.00 billion shares in issue. – Repurchase Mandate: permits on-market buy-backs of up to 400.00 million shares, or 10% of the issued share capital. – Extension Mandate: allows the number of shares repurchased to be added to the issuance limit. The Board states it has no immediate plan to use either mandate.

• Board composition – Re-election of four directors: executive directors Mr Jia Zhengyi and Mr Zhang Xiaolong, non-executive director Mr Lin Qihao, and independent non-executive director Mr Chan Wai Dune. – Mr Chan’s independence has been affirmed under Rule 3.13 of the Listing Rules.

• Auditor – Ascenda Cachet CPA Limited is nominated for re-appointment for the year ending 31 December 2026; remuneration to be set by the Board.

• Shareholder logistics – Register of members closes 21–27 May 2026; record date is 27 May 2026. – Shareholders must lodge transfer documents by 4:30 p.m. on 20 May 2026 to qualify for voting. – All resolutions will be decided by poll.

WellCell currently has no Treasury Shares and confirms that any future buy-backs will be funded from legally available resources without compromising working capital. Completion and return of the proxy form will not preclude shareholders from attending and voting in person.